The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Headquarters relocation for Lenovo Group Ltd.
Represented Lenovo Group Ltd. in connection with securing of a new U.S. headquarters location, including negotiating a multimillion dollar incentives more
Sale of intellectual property for Hatch Medical LLC
Represented Hatch Medical LLC, seller, in $21 million sale of intellectual property related to medical device more
Construction dispute for major national general contractor
Represented a national general contractor in multimillion dollar dispute against a local hospital. The case involved significant delays and more
Technology license for a networking equipment company
Represented networking equipment company in technology license. more